Related references
Note: Only part of the references are listed.Expansion of Tumor-reactive T Cells From Patients With Pancreatic Cancer
Qingda Meng et al.
JOURNAL OF IMMUNOTHERAPY (2016)
Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression
Muhammad S. Alam et al.
NATURE MEDICINE (2015)
Manipulating the Tumor Microenvironment Ex Vivo for Enhanced Expansion of Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy
Jessica Ann Chacon et al.
CLINICAL CANCER RESEARCH (2015)
Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies
K. Sideras et al.
CANCER TREATMENT REVIEWS (2014)
Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy
Simon Turcotte et al.
CLINICAL CANCER RESEARCH (2014)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Immunotherapy Converts Nonimmunogenic Pancreatic Tumors into Immunogenic Foci of Immune Regulation
Eric R. Lutz et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Y. Ino et al.
BRITISH JOURNAL OF CANCER (2013)
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Sylvie Rusakiewicz et al.
CANCER RESEARCH (2013)
Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Phenotype and Function of T Cells Infiltrating Visceral Metastases from Gastrointestinal Cancers and Melanoma: Implications for Adoptive Cell Transfer Therapy
Simon Turcotte et al.
JOURNAL OF IMMUNOLOGY (2013)
Identifying people at a high risk of developing pancreatic cancer
Alison P. Klein
NATURE REVIEWS CANCER (2013)
Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
Lauren J. Bayne et al.
CANCER CELL (2012)
Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes
Kevin M. Friedman et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Efficacy of Adoptive Cell Transfer of Tumor-infiltrating Lymphocytes After Lymphopenia Induction for Metastatic Melanoma
Shari Pilon-Thomas et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Circulating CD4+CD25+ Regulatory T Cells in Patients With Pancreatic Cancer
Tomohisa Yamamoto et al.
PANCREAS (2012)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
Potential targets for pancreatic cancer immunotherapeutics
Lindzy F. Dodson et al.
IMMUNOTHERAPY (2011)
Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer
Lucia De Monte et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
CD8+ Enriched Young Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Mark E. Dudley et al.
CLINICAL CANCER RESEARCH (2010)
Enrichment of CD8+ Cells From Melanoma Tumor-infiltrating Lymphocyte Cultures Reveals Tumor Reactivity for Use in Adoptive Cell Therapy
Peter A. Prieto et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
Takashi Inozume et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Pancreatic Cancer
Manuel Hidalgo
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer
Martin Loos et al.
CANCER LETTERS (2008)
Effective Depletion of Regulatory T Cells Allows the Recruitment of Mesothelin-Specific CD8+ T Cells to the Antitumor Immune Response Against a Mesothelin-Expressing Mouse Pancreatic Adenocarcinoma
Ihid C. Leao et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2008)
B7-H1 up-regulated expression in human pancreatic carcinoma tissue associates with tumor progression
Lei Geng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
Douglas C. Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Dynamics of the immune reaction to pancreatic cancer from inception to invasion
Carolyn E. Clark et al.
CANCER RESEARCH (2007)
Loss of expression of antigen-presenting molecules in human pancreatic cancer and pancreatic cancer cell lines
H. Pandha et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Clinical significance and therapeutic potential of the programmed death-1 ligand/programmed death-1 pathway in human pancreatic cancer
Takeo Nomi et al.
CLINICAL CANCER RESEARCH (2007)
Clinical roles of increased populations of Foxp3+CD4+ T cells in peripheral blood from advanced pancreatic cancer patients
Tetsuya Ikemoto et al.
PANCREAS (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells
Sergio A. Quezada et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Naturally occurring T-cell response against mutated p21 ras oncoprotein in pancreatic cancer
B Kubuschok et al.
CLINICAL CANCER RESEARCH (2006)
CD8(+) T-cell memory in tumor immunology and immunotherapy
Christopher A. Klebanoff et al.
IMMUNOLOGICAL REVIEWS (2006)
High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients
FH Schmitz-Winnenthal et al.
CANCER RESEARCH (2005)
CD8(+) tumor-infiltrating lymphocytes together with CD4(+) tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
A Fukunaga et al.
PANCREAS (2004)
Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+ CD25+ T cells
GL Stephens et al.
JOURNAL OF IMMUNOLOGY (2004)
Ex vivo identification, isolation and analysis of tumor-cytolytic T cells
V Rubio et al.
NATURE MEDICINE (2003)
Gytotoxic T lymphocyte mediated recognition of human pancreatic cancer cells
M Peiper et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer
N Suzuki et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Share Paper
